Oral peptide delivery has long been considered the holy grail of peptide drug development, and recent breakthroughs are bringing this goal closer to reality. The global oral proteins and peptides market is projected to grow from USD 9.31 billion in 2025 to USD 19.93 billion by 2030 at a CAGR of 16.4%[reference:123], reflecting the growing importance of oral peptide formulations.
The challenge of oral peptide delivery is formidable. Peptides are large, hydrophilic molecules that are poorly absorbed across the intestinal epithelium. They are also susceptible to degradation by digestive enzymes and the acidic environment of the stomach. Overcoming these barriers requires innovative formulation approaches.
Recent breakthroughs include the development of permeation enhancers that temporarily increase intestinal permeability, enabling peptide absorption. Novo's Wegovy pill for weight loss debuted in early January 2026, notching more than 18,400 prescriptions in its first week[reference:124]. Lilly's orforglipron pill for weight loss is currently under expedited FDA review[reference:125]. These developments represent significant progress in oral peptide delivery.
Other approaches to oral peptide delivery include enteric coatings that protect peptides from stomach acid, enzyme inhibitors that reduce degradation, and nanoparticle formulations that enhance absorption. Each approach has advantages and limitations, and the optimal strategy depends on the specific peptide and therapeutic application.
Despite these breakthroughs, challenges remain. Oral bioavailability of peptides is still low compared to subcutaneous administration, requiring higher doses and increasing cost. Variability in absorption between patients can also be a concern. Ongoing research is focused on improving bioavailability, reducing variability, and expanding the range of peptides that can be delivered orally.
At PeptideHub, we support oral peptide development with custom synthesis of peptides for formulation studies. Our experienced team can provide guidance on peptide properties that affect oral delivery, supporting the development of next-generation oral peptide therapeutics.